INSIGHT-005: A new stratum of the explorative, open-labeled, phase I INSIGHT study to evaluate the feasibility and safety, as well as preliminary efficacy, of subcutaneous injections with IMP321 (eftilagimod alpha) in combination with PD-L1 inhibitor (avelumab) for metastatic or unresectable locally advanced urothelial carcinoma (UC)-IKF-s614
JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Erscheinungsjahr: 2024
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Tsaur, Igor (Autor)
Brandt, Maximilian Peter Johannes Karl (Autor)
Goekkurt, Eray (Autor)
Gruenwald, Viktor (Autor)
Pink, Daniel (Autor)
Roghmann, Florian (Autor)
Sebastian, Martin (Autor)
Zengerling, Friedemann (Autor)
Beck, Sabine (Autor)
Koch, Christine (Autor)
Riedel, Johanna (Autor)
Tenekeci, Ulas (Autor)
Mueller, Daniel Wilhelm (Autor)
Al-Batran, Salah-Eddin (Autor)
Goetze, Thorsten (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
